24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
PolyPid
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:55
Israel's NSO Group liable for hacking WhatsApp, says US judge
15:54
Unidentified drones: A challenge for the world, an opportunity for Israel
14:33
Amazon-backed robotics startup BionicHIVE shuts down with $18M debt
13:05
Full list of Israeli startup M&As in 2024
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli fintech Morning acquired for $150 million by Italy's TeamSystem
2
EU approves Nvidia’s $700M acquisition of Israeli startup Run:ai
3
Have missiles from the Iranian-backed Houthis discovered a loophole in Israeli air defenses?
4
Israeli tech’s top 10 funding rounds of 2024: Wiz sets another record
5
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
More news
PolyPid
2 stories about PolyPid
“In the biotech industry, the one thing that is missing more than anything else is funding"
17.10.21
|
CTech
Dikla Czackes Akselbrad, executive vice president and CFO of PolyPid, joins Michael Matias to discuss her bio-pharmaceutical company
Drug Conduction Company Prepares for Nasdaq IPO
08.10.17
|
Golan Hazani
Clinical stage PolyPid develops technology for the predetermined, controlled and localized release of drugs at a targeted site
Please ensure Javascript is enabled for purposes of
website accessibility